Download the article.invention
View Tag Index
| Common Sense: Treating Statutory Nonobviousness As a Novelty Issue - 313 occurances |
| Common Sense: Treating Statutory Nonobviousness As a Novelty Issue - 313 occurances |
| Disabling Patentability for Skill-Based Inventions: Aligning Patent Law with Competition Policy - 257 occurances |
| Patentability of Human-Animal Chimeras - 126 occurances |
| Necessity May be the Mother of Invention, but Who Gets Custody?: The Ownership of Intellectual Property Created by an Employed Inventor - 112 occurances |
| Windfall Property Rights for the Left Out Co-Inventor Who Gets Let Into the Patent - 104 occurances |
| Towards Developing a Natural Law Jurisprudence in the U.S. Patent System - 79 occurances |
| Patents: Hiding from History - 75 occurances |
| Reasonable Pricing – A New Twist for March-In Rights Under the Bayh-Dole Act - 74 occurances |
| Proposing Resolutions to the Inssufficient Gene Patent System - 73 occurances |
| Calibrating Patent Lifetimes - 72 occurances |
| Assignor Estoppel: Fairness at what Price? - 64 occurances |
| KSR: It Was Not A Ghost - 56 occurances |
| Schering Corp. v. Geneva Pharmaceuticals, Inc.: Just How Far can Inherent Anticipation Extend? - 51 occurances |
| Biomedical Patenting: Permitted, But Permissible? - 41 occurances |
| Current Patent Protection Granted for Genetically Modified Organisms under the European Patent Convention and the Scandal of EP 0695351 - 41 occurances |
| Control of Inventions in a Networked World - 39 occurances |
| Transaction Costs and Patent Reform - 37 occurances |
| The Test of Primary Cloning: A New Approach to the Written Description Requirement in Biotechnological Patents - 36 occurances |
| Biotechnology: Highlights of the Science and Law Shaping the Industry - 36 occurances |
| Patent Rules of Evidence - 32 occurances |
| Protecting Academic and Non-Profit Research: Creating a Compulsory Licensing Provision in the Absence of an Experimental Use Exception - 29 occurances |
